About Hilo by Aktiia
High blood pressure is the world’s most common disease, causing 18M deaths each year. At Hilo by Aktiia, our vision is a world where no lives are lost or damaged from the effects of high blood pressure. Our mission is to make this a reality by developing tech to help people control their blood pressure.
We are a venture-backed scale-up company, having raised over $96M from investors in Europe and the United States. Our technology - rooted in 18 years of research at the Swiss Center for Electronics and Microtechnology (CSEM) - is the world’s only medically accurate, continuous blood pressure monitor that is cuffless in daily life in the consumer space. Validated through extensive clinical trials and CE Marked as a Class IIa medical device, our solution is now available in 12 countries. We are a hybrid/remote-first company, with Headquarters in Neuchâtel, Switzerland, united by our passion for impact and innovation.
Currently, we are looking for a Chief Medical Officer to lead the medical and clinical strategy for our scaling company.
As a Chief Medical Officer you will define the most clinically impactful use cases, guide product development, and champion adoption of our technology across the healthcare ecosystem.
This is a rare opportunity to transform hypertension care through a unique cardiovascular dataset and a world-class interdisciplinary team. Reporting directly to the CEO, you will serve as the bridge between clinical excellence, product innovation, and commercial strategy - ensuring that our technology earns the trust of clinicians, regulators, and customers alike.
We are a 70-person medtech scale-up, currently focused on Europe with a clear strategy to expand into the US market. You will play a pivotal role in both scientific credibility and business growth as we enter this next phase.
If you’re a clinician-entrepreneur who thrives in a fast-moving, collaborative environment and wants to drive meaningful change in global cardiovascular health - with the opportunity to improve outcomes for hundreds of thousands of hypertension sufferers - we’d love to hear from you.
This is a full-time role, though we encourage you to continue practising medicine alongside your leadership responsibilities. We believe that when it comes to hypertension management, only a medically sound approach can define the future. As the highest medical authority in the company, this role will shape that future.
We are a hybrid/remote company spread across Europe Nevertheless, this role requires traveling within Europe and regular presence in our office in Neuchâtel, Switzerland. As the UK and German speaking countries are currently our main markets, a candidate located in one of these countries is preferred.
USP:
This CMO role combines true medical authority, direct CEO partnership and ownership of the world’s first continuous blood pressure dataset at scale, with the freedom to shape how hypertension is managed globally.
Core Responsibilities:
Strategic Leadership & Clinical Direction
Collaboration & Cross-Functional Partnership
Market Engagement & Advocacy
Change Leadership & Influence
Requirements
Background & Experience
What Success Looks Like
What Makes You A Great Fit
At Hilo by Aktiia, our values guide everything we do:
Move the Needle
Move Fast, Learn, Refine
Team First
Benefits
Ready to Move the Needle?
If you are passionate about making a meaningful impact in people's lives and excel in an environment where individuals take ownership and are committed to delivering results, we are happy to receive your application.

Aktiia, now trading under Hilo, was established in 2018 to transform how blood pressure is measured and therefore managed.
Hilo is transforming blood pressure monitoring with cuffless, AI-powered technology that delivers continuous, accessible insights for individuals and healthcare professionals. Our foundation model is trained on billions of optical signals and hundreds of millions of readings from over 120,000 users—one of the largest datasets in the field. Backed by a multidisciplinary team with deep expertise in biomedical signal processing, Hilo has contributed to over 120 peer-reviewed publications and holds more than 35 patents. Headquartered in Switzerland, we’re expanding globally to redefine how blood pressure is measured and managed.